Connection

SOPHIA TSAI to Male

This is a "connection" page, showing publications SOPHIA TSAI has written about Male.
Connection Strength

0.262
  1. Increased COUP-TFII expression in adult hearts induces mitochondrial dysfunction resulting in heart failure. Nat Commun. 2015 Sep 10; 6:8245.
    View in: PubMed
    Score: 0.021
  2. COUP-TFII inhibits TGF-?-induced growth barrier to promote prostate tumorigenesis. Nature. 2013 Jan 10; 493(7431):236-40.
    View in: PubMed
    Score: 0.017
  3. Nuclear receptor COUP-TFII controls pancreatic islet tumor angiogenesis by regulating vascular endothelial growth factor/vascular endothelial growth factor receptor-2 signaling. Cancer Res. 2010 Nov 01; 70(21):8812-21.
    View in: PubMed
    Score: 0.015
  4. Direct transcriptional regulation of neuropilin-2 by COUP-TFII modulates multiple steps in murine lymphatic vessel development. J Clin Invest. 2010 May; 120(5):1694-707.
    View in: PubMed
    Score: 0.014
  5. Suppression of ERalpha activity by COUP-TFII is essential for successful implantation and decidualization. Mol Endocrinol. 2010 May; 24(5):930-40.
    View in: PubMed
    Score: 0.014
  6. Essential roles of COUP-TFII in Leydig cell differentiation and male fertility. PLoS One. 2008 Sep 26; 3(9):e3285.
    View in: PubMed
    Score: 0.013
  7. COUP-TFII mediates progesterone regulation of uterine implantation by controlling ER activity. PLoS Genet. 2007 Jun; 3(6):e102.
    View in: PubMed
    Score: 0.012
  8. Cdc25B as a steroid receptor coactivator. Vitam Horm. 2004; 68:231-56.
    View in: PubMed
    Score: 0.009
  9. Overexpression of Cdc25B, an androgen receptor coactivator, in prostate cancer. Oncogene. 2003 Feb 06; 22(5):734-9.
    View in: PubMed
    Score: 0.009
  10. Ectopic expression of FGF-3 results in abnormal prostate and Wolffian duct development. Oncogene. 2002 Mar 14; 21(12):1899-908.
    View in: PubMed
    Score: 0.008
  11. Elevated COUP-TFII expression in dopaminergic neurons accelerates the progression of Parkinson's disease through mitochondrial dysfunction. PLoS Genet. 2020 06; 16(6):e1008868.
    View in: PubMed
    Score: 0.007
  12. Small-molecule inhibitor targeting orphan nuclear receptor COUP-TFII for prostate cancer treatment. Sci Adv. 2020 05; 6(18):eaaz8031.
    View in: PubMed
    Score: 0.007
  13. Small molecule JQ1 promotes prostate cancer invasion via BET-independent inactivation of FOXA1. J Clin Invest. 2020 04 01; 130(4):1782-1792.
    View in: PubMed
    Score: 0.007
  14. The orphan nuclear receptor COUP-TFII is required for angiogenesis and heart development. Genes Dev. 1999 Apr 15; 13(8):1037-49.
    View in: PubMed
    Score: 0.007
  15. COUP-TF upregulates NGFI-A gene expression through an Sp1 binding site. Mol Cell Biol. 1999 Apr; 19(4):2734-45.
    View in: PubMed
    Score: 0.007
  16. Elimination of the male reproductive tract in the female embryo is promoted by COUP-TFII in mice. Science. 2017 08 18; 357(6352):717-720.
    View in: PubMed
    Score: 0.006
  17. Decreased epithelial progesterone receptor A at the window of receptivity is required for preparation of the endometrium for embryo attachment. Biol Reprod. 2017 02 01; 96(2):313-326.
    View in: PubMed
    Score: 0.006
  18. COUP-TFII regulates satellite cell function and muscular dystrophy. J Clin Invest. 2016 10 03; 126(10):3929-3941.
    View in: PubMed
    Score: 0.005
  19. Dysregulation of miRNAs-COUP-TFII-FOXM1-CENPF axis contributes to the metastasis of prostate cancer. Nat Commun. 2016 04 25; 7:11418.
    View in: PubMed
    Score: 0.005
  20. MPC1, a key gene in cancer metabolism, is regulated by COUPTFII in human prostate cancer. Oncotarget. 2016 Mar 22; 7(12):14673-83.
    View in: PubMed
    Score: 0.005
  21. Isolation, characterization, and chromosomal localization of mouse and human COUP-TF I and II genes. Genomics. 1995 Sep 01; 29(1):240-6.
    View in: PubMed
    Score: 0.005
  22. Estrogen receptor-a in medial amygdala neurons regulates body weight. J Clin Invest. 2015 Jul 01; 125(7):2861-76.
    View in: PubMed
    Score: 0.005
  23. Androgen deprivation-induced NCoA2 promotes metastatic and castration-resistant prostate cancer. J Clin Invest. 2014 Nov; 124(11):5013-26.
    View in: PubMed
    Score: 0.005
  24. NR2F1 mutations cause optic atrophy with intellectual disability. Am J Hum Genet. 2014 Feb 06; 94(2):303-9.
    View in: PubMed
    Score: 0.005
  25. COUP-TFII, a prognostic marker and therapeutic target for prostate cancer. Asian J Androl. 2013 May; 15(3):360-1.
    View in: PubMed
    Score: 0.004
  26. COUP-TFII is essential for metanephric mesenchyme formation and kidney precursor cell survival. Development. 2012 Jul; 139(13):2330-9.
    View in: PubMed
    Score: 0.004
  27. Coup d'Etat: an orphan takes control. Endocr Rev. 2011 Jun; 32(3):404-21.
    View in: PubMed
    Score: 0.004
  28. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma. J Natl Cancer Inst. 2009 Feb 04; 101(3):162-75.
    View in: PubMed
    Score: 0.003
  29. The nuclear orphan receptor COUP-TFII plays an essential role in adipogenesis, glucose homeostasis, and energy metabolism. Cell Metab. 2009 Jan 07; 9(1):77-87.
    View in: PubMed
    Score: 0.003
  30. Steroid receptor coactivator-3/AIB1 promotes cell migration and invasiveness through focal adhesion turnover and matrix metalloproteinase expression. Cancer Res. 2008 Jul 01; 68(13):5460-8.
    View in: PubMed
    Score: 0.003
  31. COUP-TFI coordinates cortical patterning, neurogenesis, and laminar fate and modulates MAPK/ERK, AKT, and beta-catenin signaling. Cereb Cortex. 2008 Sep; 18(9):2117-31.
    View in: PubMed
    Score: 0.003
  32. Steroid receptor coactivator-3 and activator protein-1 coordinately regulate the transcription of components of the insulin-like growth factor/AKT signaling pathway. Cancer Res. 2006 Nov 15; 66(22):11039-46.
    View in: PubMed
    Score: 0.003
  33. Oncogenic steroid receptor coactivator-3 is a key regulator of the white adipogenic program. Proc Natl Acad Sci U S A. 2006 Nov 21; 103(47):17868-73.
    View in: PubMed
    Score: 0.003
  34. SRC-3/AIB1: transcriptional coactivator in oncogenesis. Acta Pharmacol Sin. 2006 Apr; 27(4):387-94.
    View in: PubMed
    Score: 0.003
  35. SRC-3 is required for prostate cancer cell proliferation and survival. Cancer Res. 2005 Sep 01; 65(17):7976-83.
    View in: PubMed
    Score: 0.003
  36. Roles of steroid receptor coactivator (SRC)-1 and transcriptional intermediary factor (TIF) 2 in androgen receptor activity in mice. Proc Natl Acad Sci U S A. 2005 Jul 05; 102(27):9487-92.
    View in: PubMed
    Score: 0.003
  37. Role of the steroid receptor coactivator SRC-3 in cell growth. Mol Cell Biol. 2003 Nov; 23(21):7742-55.
    View in: PubMed
    Score: 0.002
  38. Regulable expression of inhibin A in wild-type and inhibin alpha null mice. Mol Endocrinol. 2000 Jul; 14(7):1075-85.
    View in: PubMed
    Score: 0.002
  39. The nuclear orphan receptor COUP-TFI is required for differentiation of subplate neurons and guidance of thalamocortical axons. Neuron. 1999 Dec; 24(4):847-59.
    View in: PubMed
    Score: 0.002
  40. Molecular mechanisms of androgen-independent growth of human prostate cancer LNCaP-AI cells. Endocrinology. 1999 Nov; 140(11):5054-9.
    View in: PubMed
    Score: 0.002
  41. Androgen regulation of the cyclin-dependent kinase inhibitor p21 gene through an androgen response element in the proximal promoter. Mol Endocrinol. 1999 Mar; 13(3):376-84.
    View in: PubMed
    Score: 0.002
  42. Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science. 1998 Mar 20; 279(5358):1922-5.
    View in: PubMed
    Score: 0.002
  43. Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI p16 genes. Cancer Res. 1997 Oct 15; 57(20):4511-6.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.